Welcome to RadioMedix

Radiomedix,Inc. was founded in 2006 to develop and commercialize technology and products which will enable on-site and on-demand access to Positron Emission Tomography ("PET"). RadioMedix is developing its own chelation technology (Multi-Application Chelators, MAC) and new imaging conjugates, GlucoMedix^TM and OncoMedix^TM, which have the potential to significantly improve diagnosis and treatment monitoring for a variety of cancers. RadioMedix’s automated SyntheMedix^TM system, coupled with a small generator producing a PET isotope such as Gallium-68 (⁶⁸Ga),  will permit users to generate and label PET radiotracers on-site at a significantly reduced cost, without the need for access to cyclotron facilities which generate radioisotopes such as Fluorine-18 (¹⁸F ).